At this year’s ABRF Annual Meeting (23–26 March; NV, USA), biotech companies had the opportunity to showcase their technology ...

Swiss National Bank boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 188,400 ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Find the latest IO Biotech news from Fast company. See related business and technology articles, photos, slideshows and videos.

The firm is using single-cell, multiomics analysis to probe tumor samples from very long-term cancer survivors for keys to defeating the disease.

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

The project, titled ‘Corsa’ promises a 10x speed boost for developers, along with a ‘substantial’ reduction in memory usage. Anders Hejlsberg, the lead architect of TypeScript, and a technical fellow ...

Dassault Aviation’s ultra-long-range Falcon 10X business jet remains on track to hit a revised service-entry target in late 2027, but the French airframer is staying tight-lipped on when its ...